Exploring human plasma proteomic variations in mucolipidosis type IV.

Tobin BR, Misko A, Miller-Browne V, Sangster M, Grishchuk Y, Wood LB

Open source

DOI
10.1016/j.omtm.2025.101479
Published
2025 Jun 12
Container
Molecular therapy. Methods & clinical development
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtm.2025.101479,
  title = {Exploring human plasma proteomic variations in mucolipidosis type IV.},
  author = {Tobin BR and Misko A and Miller-Browne V and Sangster M and Grishchuk Y and Wood LB},
  year = {2025},
  journal = {Molecular therapy. Methods \& clinical development},
  doi = {10.1016/j.omtm.2025.101479},
  url = {https://doi.org/10.1016/j.omtm.2025.101479}
}

RIS

TY  - JOUR
TI  - Exploring human plasma proteomic variations in mucolipidosis type IV.
AU  - Tobin BR
AU  - Misko A
AU  - Miller-Browne V
AU  - Sangster M
AU  - Grishchuk Y
AU  - Wood LB
PY  - 2025
JO  - Molecular therapy. Methods & clinical development
DO  - 10.1016/j.omtm.2025.101479
UR  - https://doi.org/10.1016/j.omtm.2025.101479
ER  - 

APA

BR, T., A, M., V, M., M, S., Y, G., & LB, W. (2025). Exploring human plasma proteomic variations in mucolipidosis type IV.. Molecular therapy. Methods & clinical development. https://doi.org/10.1016/j.omtm.2025.101479

Source records